We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$397M
AUM Growth
+$14.8M
Cap. Flow
+$3.91M
Cap. Flow %
0.99%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$3.91M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 94.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
1
DELISTED
Abiomed Inc
ABMD
$158M 39.93%
1,450,000
– –
ENTL
2
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$69.7M 17.55%
3,813,197
– –
RVNC
3
DELISTED
Revance Therapeutics, Inc.
RVNC
$62.5M 15.74%
4,592,047
– –
AXGN icon
4
Axogen
AXGN
$2.59B
$33.4M 8.43%
4,861,111
– –
CORI
5
DELISTED
Corium International, Inc.
CORI
$32.5M 8.18%
9,353,304
– –
ELGX
6
DELISTED
Endologix Inc
ELGX
$22.2M 5.59%
125,747
– –
MNOV icon
7
MediciNova
MNOV
$65M
$8.84M 2.23%
1,170,370
– –
LGND icon
8
Ligand Pharmaceuticals
LGND
$6.42B
$3.92M 0.99%
+52,727
New +$3.91M
ACUR
9
DELISTED
Acura Pharmaceuticals
ACUR
$3.62M 0.91%
1,956,397
– –
GYRE icon
10
Gyre Therapeutics
GYRE
$749M
$1.82M 0.46%
10,483
– –

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
LIA
LifePlan Investment Advisors Raleigh, North Carolina $254M AUM 17.26% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return

Essex Woodlands Management's Q2 2016 Portfolio in Review

As of Q2 2016, Essex Woodlands Management held 10 positions worth $397M, up 3.9% from $382M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management's Q2 2016 filing shows 1 new position. Its largest new stake was Ligand Pharmaceuticals: 52,727 shares worth $3.92M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 96% a quarter earlier.

  • Essex Woodlands Management's largest Q2 2016 buy was Ligand Pharmaceuticals: 52,727 shares worth $3.92M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $397M portfolio in Q2 2016.
  • Essex Woodlands Management opened 1 new position and closed 0 in Q2 2016.
  • Essex Woodlands Management's portfolio value rose 3.9% quarter-over-quarter to $397M.

Based on Essex Woodlands Management's 13F filing for Q2 2016, filed 9 Aug 2016.